Article: Early Nicotinamide Riboside Supplementation Shows Promise in an Individual with Ataxia Telangiectasia: Case Report

Oct 12, 2022 Ataxia Telangiectasia Case Studies Neurological Health

Early Nicotinamide Riboside Supplementation Shows Promise in an Individual with Ataxia Telangiectasia: Case Report

Objective

To investigate the effects of NR supplementation in a 3.5-year-old male child with ataxia and recurrent bacterial infections. This was a case study of one individual.

Journal

Neuropediatrics

Key Outcomes

NR supplementation resulted in no adverse effects.
Neurological examination after 7 and 11 months of NR supplementation showed a clearer and more fluid speech and improvement in fine motor skills and movement disorder.
Use of antibiotics and frequency of hospitalizations due to infections were reduced by more than 90%.
The authors stated given the absence of adverse effects, they strongly encourage to consider NR supplementation in all individuals with ataxia telangiectasia.

Duration

11 Months

Dose

25 mg/kg

Study Design

Clinical case study in 1 3.5-year-old child of Syrian parents

See Published Study

Healthy Aging & Longevity

Emerging Role of Nicotinamide Riboside in Health and Diseases: Review

SynopsisAmong NAD⁺ precursors, nicotinamide riboside (NR) stands out for its safety, effectiveness, and oral bioavailability. A newly identified form of vitamin B3, NR boosts NAD+ in cells and has ...

Clinical

Nicotinamide Riboside Supplementation Raises NAD+ and Lowers Alzheimer's-Associated Biomarkers: Clinical Findings

Objectives To evaluate if NR could augment neuronal NAD+ levels and impact markers of neurodegeneration and insulin-signaling in plasma-derived human neuronal extracellular vesicles (NEVs). Journa...